Brainscape's Knowledge GenomeTM

Browse over 1 million classes created by top students, professors, publishers, and experts.


See full index

Y3 Med Pharmaceutics sem 1 > Inhalation drug delivery > Flashcards

Inhalation drug delivery Flashcards

1
Q

What are the benefits or inhalation medication?

A

• Rapid onset of drug action
• Avoids GI degradation
• Avoids first pass metabolism
• Use of lower doses reduces ADRs
• Accurate dose adjustment & titration to individual needs and ideal for PRN (as needed) medication
• Use of small volumes (25 – 100 mL)
• Tamperproof containers
• Protect from instabilities due to air, moisture
• Provides a useful alternative route of drug administration:
o For acute and breakthrough pain treatment
o Where physical and/or chemical interactions with other medications must be avoided
o When the drug exhibits variable or erratic pharmacokinetics when given orally
o When critical to avoid GI degradation of the therapeutic agent e.g. biologics

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What makes up the upper respiratory tract?

A

Buccal, sub-lingual, and nasal cavities, pharynx, upper larynx (above the vocal cards)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What size particles do the nasal cavity filter out?

A

Large particles (>15 micrometres), go to mouth to swallow or cough/sneeze (expel)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What covers the entrance to airways when swallowing?

A

Epiglottis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What makes up the lower respiratory tract?

A

Trachea - branching to primary and then secondary bronchi, then branching to bronchioles and terminating in alveoli

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

How many alveoli are there per lung?

A

300 million (70 m^2 surface area)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What is the extent of particle deposition affected by?

A

o Product characteristics:
 Dry powder: particle diameter, shape, density,
charge, and surface chemistry
 Liquid aerosol: droplet size distribution,
velocity, nature of propellant
o Anatomical and physiological characteristics:
 Geometry of the respiratory tract
 Lung capacity
 Breathing patterns (frequency, tidal volume)
 Pathology

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What is inertial impaction?

A

Momentum of particle renders it unable to follow the airflow in a curved airway so that it impacts on the wall – finds it hard to deviate round the corner (larger particles)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What is gravitational sedimentation?

A

related to the Residence time in an airway & terminal settling velocity, increased by holding breath – heavier particles settle first

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What is Brownian diffusion?

A

Random collision of particle with airway wall; significant only for particles < 0.1 mm (small)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What is electrostatic attraction?

A

Charge on particle induces opposite charge on airway wall and accelerates particle into wall – narrow airways

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What is interception?

A

Particle size approaches airway diameter

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What is the relationship between deposition by impaction and sedimentation and particle size?

A

Deposition by impaction and sedimentation are directly proportional to particle size; most significant for particles > 1micrometres

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What is the relationship between deposition by diffusion and particle size?

A

Deposition by diffusion is inversely related to particle size; significant only for sub-micron sized particles

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

How is deposition achieved in traditional delivery services?

A

Through impaction and sedimentation; particles < 10 mm (typically, 2 – 8 mm); 80-90% of dose not deposited; large losses to GI absorption (& side effects)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

How is improved deposition achieved in inhalers?

A

Improved deposition achieved in inhalers emitting smaller particles at lower velocities (only 50% - 70% losses) with > 30% deposition achieved in peripheral airways

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

What inhalation devices are useful for upper respiratory tract?

A

Sprays

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

What inhalation device uses solvent propellant and was banned because of this?

A

Pressurised metered dose inhalers (pMDIs)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

What inhalation device is useful for small airways diseases?

A

Superfine particle inhalers

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

What are nebulisers?

A

drug dispersed in polar solvent (usually H2O); cumbersome; mainly used in hospitals and in ambulatory care; recent smaller aerosolisation developments

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

What are Dry Powder Inhalers?

A

replacing pMDIs; no solvent propellant (thus, no environmental issues); dry powder fluidises when patient inhales; drug shears from larger particles and so penetrates deeper into the lungs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

What are nasal sprays used for?

A

Used for hay fever medications (antihistamines), treatment of sinusitis (steroids), and in decongestants

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

What is ViaNase?

A

From Kurve Technology; uses electronic atomiser to give controlled particle dispersion (with narrow size range: 10 – 30 mm); minimises pulmonary and GI deposition

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

What is Optinose?

A

Uses bidirectional flow – exploiting the blow reflex (exhalation delivery system) – to ensure large particles go to the nasal mucosa and prevent smaller particles going down into the lungs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

What do pMDIs do?

A
  • Use liquid propellant (HFAs now, not CFCs)
  • Generate fast moving micro-fine suspensions;
  • Slow and deep inhalation down into lungs;
  • Patient inhales and valve operates simultaneously; manually operated valves, breath-actuated valves, battery-activated valves;
  • Dose counters incorporated
  • Excipients: co-solvent (ethanol), inverse micelles, or liposomes to enhance solubility of surfactant propellants; surfactants (e.g., lecithin, oleic acid), to adsorb to particles & prevent agglomeration (shake before use); menthol, flavouring; ascorbic acid, antioxidant; phenylethanol, preservative
26
Q

Why would 20 micrometres sized particles deposit largely in the upper airways with little deposition in the lower airways, and why would less than 10% of these particles escape from the airways?

A

o Large particle – sediments in the first place it comes across, - more likely to impact and deposit on the walls of the upper airways, and if the flow rate of the air is low and/or if the residence time is longer (with the inhaling individual holding their breath), some will also be deposited on these walls as a result of gravitational sedimentation
o A relatively small fraction of the 20micrometre particles will penetrate to the lower respiratory tract, and those that do will deposit there through gravitational sedimentation
o Only a very low proportion of the 20um particles will thus escape deposition and remain in the exhaled

27
Q

What would be the fate of a significant proportion of the 20 mm sized particles & where would their drug payload be likely to be absorbed?

A 
o	Upper (ciliated) airways (particles get stuck in mucus), mouth or throat – could get swallowed and then end up in the stomach (GI tract)
o	Drug will be enzymatically degraded in the stomach
28
Q

Why would particles of 6 mm & 2 mm in size be deposited largely in the lower airways, with little deposition in the upper airways, and why would more than 50% of the 2 mm sized particles but less than 20% of the 6 mm sized particles be lost from the airways?

A

o Small particles have less momentum and inertia and will impact to a lesser extent in the larger and less branched upper airways, less likely to sediment and bump into the walls of upper airways. The impaction of the 6 and 2um particles is more likely to take place in the more highly branched lower airways
o Particles have less inertia
o More of the 2-micron particles will be exhaled

29
Q

Why does no significant deposition of 0.6 mm sized particles occur in upper airways & why little deposition also in the lower airways, such that over 80% of the particles would be lost from the airways?

A

o Sub-micron particles will have very low momentum and so will be unlikely to impact in the upper or lower airways and since they have very low mass, their deposition through gravitational sedimentation will also be significant
o The particles may deposit through Brownian diffusion to a limited extent but this mechanism of deposition Is only really significant for particles < 0.5 mm and so most of the 6 mm particles will not deposit anywhere in the airways and will instead be exhaled.

30
Q

Which particle size is most favourable for systemic delivery of drug & why?

A

o Given the greater level of deposition and the higher retention of 6mm particles in the lower airways, particles of this size will be the more effective in providing for drug absorption into the blood circulation for systemic delivery.
o The lower airways are non-ciliated, present a high surface area for absorption, and have a rich blood supply

31
Q

Where do most particles generated in traditional pMDIs and DPIs deposit?

A

In the wider upper airways by sedimentation and impaction

32
Q

What diseases are inadequately treated using traditional inhalers?

A

Small airways diseases conditions (e.g. COPD, chronic asthma)

33
Q

What size are small airways?

A

<2mm diameter - major sire of airflow limitation

34
Q

What happens to particles 0.5-1mm?

A

Deposited poorly, with most exhaled

35
Q

What size are extra-fine particles?

A

<1mm**?

36
Q

What size are ultra-fine particles?

A

<100nm

37
Q

What are the extra-thoracic regions?

A

Neck upwards

38
Q

What are the differences in deposition between thoracic (TH) and extra-thoracic (ET) regions for particles 1-9 (2.8) micron?

A

1 – 9 (2.8) micron size gives high ET (throat) (high throat deposition means particles may end up in the stomach - swallowed) deposition, with < 30% deposited in TH region, largely due to inertial impaction. Particles that escape impaction are well-dispersed in TH region, but there are no regions of high deposition to benefit small airways disease

39
Q

What are the differences in deposition between thoracic (TH) and extra-thoracic (ET) regions for particles 0.25-1 micron?

A

Half of the mid-size (0.25 – 1 micron) particles deposit in ET region, as airways smaller in the child / baboon model and more would be impacted, so serving little benefit in treatment of small airways disease

40
Q

What are the differences in deposition between thoracic (TH) and extra-thoracic (ET) regions for particles 0.15-0.5 micron?

A

Ultrafine 0.15 – 0.5-micron (230 nm) size much less ET deposition, as low impaction, with diffusional deposition contributing to strong well-dispersed TH deposition –> better deposition in the thoracic region as they are small enough to reach that area and deposit via Brownian diffusion

41
Q

What increases with particle size?

A

Deposition

42
Q

What happens to deposition with a lower breathing rate and higher tidal volume?

A

Higher deposition due to greater contribution of sedimentation between breaths

43
Q

What is the deposition through gravitational sedimentation and inertial impaction for small particles (0.5-1 micron)?

A

LOWER and diffusional deposition is not yet significant, resulting in the loss of particles on exhalation

44
Q

What contributes far less with nanoparticles (0.01-0.5 micron)?

A

Inertial impaction and gravitational sedimentation

45
Q

Where are nanoparticels more likely to travel to?

A

Ultrafine particles are unlikely to impact or sediment in the upper airways and more likely to be inhaled into the lower, smaller airways

46
Q

Why is there a high deposition of nanoparticles in the lower, smaller airways?

A

Diffusion dominates the deposition of very small particles and is inversely related to particle size, and so there will be a high deposition of these NPs in the lower, smaller airways

47
Q

When are nebulisers used?

A

Used - in the home and in hospitals – to treat patients with conditions that render them unable to use other types of inhaler devices

48
Q

What are traditional (air jet) nebulisers?

A

compressed air or oxygen exits a narrow orifice at high velocity, creating negative pressure which draws liquid to top of tube, where it is aerosolised, giving droplets > 40 mm; very large droplets removed through impaction on bend

49
Q

What are ultrasonic nebulisers?

A

piezoelectric transducers used to focus (1- 3 MHz) ultrasound waves in liquid, with intense agitation at the focus to disperse the liquid and form aerosol

50
Q

What are vibrating mesh ultrasonic nebulisers?

A

Vibrating mesh ultrasonic nebulisers: AC causes piezo crystal to expand and contract rapidly, pulling mesh into liquid and then thrusting forward to create a monodisperse aerosol of superfine droplets (virtually all of which is appropriate for inhalation)

51
Q

What are passive breath-dispersing DPIs?

A

commercially-available devices require quick, strong and deep inhalation; small drug particles adhered to larger carrier particles – separated by sheer with large particles then being deposited in the oropharynx, and the smaller (drug) particles going down to the lower airways

52
Q

What are active DPIs?

A

in development, use an internal power source to aerosolize the powder; SpirosTM, uses a battery-powered motor, Oriel, uses a piezoelectric polymer

53
Q

What is included in the formulation of DPIs?

A

carriers (e.g., lactose) not always used; drug crystals may be used (e.g., Pulmicort (budenoside), Turbuhaler (AZ)

54
Q

How are the APIs for DPIs micronized?

A

micronized by jet, pin or ball milling, or else by spray drying or use of supercritical fluid

55
Q

What particle size shows efficient alveolar delivery?

A

particles with aerodynamic diameters of 1 – 5 microns

56
Q

What is aerodynamic diameter?

A

describes dynamic behaviour of a particle, relating gravitational settling and inertial impaction

57
Q

What can aerodynamic diameter be decreased by?

A

o decreasing (geometric) size
o decreasing density
o increasing shape factor

58
Q

What formulation would be LEAST likely to be considered to treat a fungal lung infection?

A

Dry powder inhaler with drug particles micronized to a few microns in aerodynamic diameter
–> Drug particles that are microns in size with NOT get into the lower airways, and if they are dry, they will not dissolve well

59
Q

What affect would increasing the geometric size and density, and reducing the shape factor of particles have on systemic bioavailability?

A

Increasing the geometric size and density and reducing the shape factor of the aerosol particles will all serve to increase the particle aerodynamic diameter and this will result in even more deposition in the upper airways (NOT improving bioavailability)

60
Q

Can the shape of dry powder particles be elongated by different production conditions to decrease their aerodynamic diameter?

A

YES

Y3 Med Pharmaceutics sem 1 (5 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2024 Bold Learning Solutions. Terms and Conditions